Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Cardiovascular Diseases × Genetic Testing × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 2 Wilms Tumor 1 Unspecified Childhood Solid Tumor, Protocol Specific 1 Spinal Cord Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Hepatic Veno-Occlusive Disease 1 Endometrial Hyperplasia 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cardiovascular Diseases 1 Breast Neoplasms 1

Interventions

Gonadotropin-Releasing Hormone 2 xinmailong 1 palbociclib 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Vitamin B 6 1 Vitamin B 12 1 Testosterone 1 Rivaroxaban 1 Progesterone 1 Physical Conditioning, Human 1 Genetic Testing 1 Folic Acid 1 Estradiol 1 DNA 1 Cardiovascular Agents 1 Blood Specimen Collection 1 Blood Pressure 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02485626 2016-10-31

HARBOR

The Netherlands Cancer Institute

Breast Neoplasms, Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡